Funded Research
​
The PACS1 Syndrome Research Foundation has committed over
1.4 million dollars in funding towards scientific research.The PACS1 Syndrome Research Foundation is PURELY research focused, funding scientific research towards finding a cure for PACS1 Syndrome. We do not have an advocacy wing.​​​
ACKNOWLEDGING OUR MAJOR DONORS
​
NONE OF THIS PROGRESS WOULD BE POSSIBLE WITHOUT THE GENEROUS SUPPORT OF THE FAMILIES AND ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ADVANCING PACS1 SYNDROME RESEARCH:
​
-
THE REDDY-VASSALLI FAMILY (PARENTS OF ALYA): DONATION OF $1,000,000.
​​
-
MEL AND SANDRA DEANE (PARENTS OF JAMES): DONATED $500,000 WITH A PLEDGE OF $1,000,000 IN TOTAL.
​​
-
CHAN ZUCKERBERG INITIATIVE: $600,000 RARE AS ONE GRANT, WHICH SUPPORTS INFRASTRUCTURE, TECHNOLOGY, AND CAPACITY BUILDING, ALLOWING US TO FOCUS ON CRITICAL RESEARCH EFFORTS BELOW.
​​
THANK YOU FOR HELPING US DRIVE PROGRESS TOWARD TREATMENTS FOR PACS1 PATIENTS.
We fund the most promising basic and translational research that could lead to the development of new treatments in the coming years. The Scientific Advisory Board (SAB) of the PACS1 Syndrome Research Foundation reviews all research proposals and projects under consideration by the Foundation. Proposals are evaluated based on the investigator's expertise, the work plan, research objectives, and the project's potential to accelerate the development of treatments for PACS1 patients.
​
Please note that the PACS1 Syndrome Research Foundation does not fund indirect costs, also known as overhead or facilities and administrative (F&A) costs. Our policy stipulates that all grant funds must be allocated exclusively toward program expenses essential for grant execution and directly aligned with the project's objectives.
2024
Institution: UT Southwestern Medical Center
Principal Investigator: Evan Nair-Gill, M.D., Ph.D.
Description: Exploring the structural biology of the PACS1 – WDR37 Connection (Year 2)
Amount: $143,560
Institution: The Broad Institute of MIT and Harvard
Principal Investigator: Jaime Cheah, Ph.D.
Description: Exploring cell-painting applications in fibroblasts to better understand PACS1 Syndrome.
Grant Amount: $16,501.47
2023
Institution: UT Southwestern Medical Center
Principal Investigator: Evan Nair-Gill, M.D., Ph.D.
Description: Exploring the structural biology of the PACS1 – WDR37 Connection
Grant Amount: $191,340
Institution: The Jackson Laboratory
Principal Investigator: Steve Murray, Ph.D.
Description: PACS1 Syndrome mouse model development and evaluation of the potential of genome editing (in particular base editing) as a therapeutic intervention for PACS1 Syndrome. Recognized as the 'Breakthrough of the Year' in 2020, base editing is a novel technique that is particularly relevant for PACS1 Syndrome,
Amount: $58,801
Research Partner: HitGen, Inc.
Description: DNA encoded library (DEL) screening initiative.
Research Commitment: $7,240
Research Partner: Across Healthcare
Description: Early-stage development of a patient data collection platform.
Research commitment: $25,000
Institution: The Broad Institute of MIT and Harvard
Principal Investigator: Jaime Cheah, Ph.D.
Description: Exploring cell-painting applications in fibroblasts to better understand PACS1 Syndrome.
Grant Amount: $20,874
2022
Research Partner: Across Healthcare
Description: PACS1 Syndrome Research Foundation owned patient data collection platform. Collect registry and natural history data on PACS1 Syndrome patients to support PACS1 Foundation research partners in furthering research, drug development and clinical trial design.
Research commitment: $25,000
​
Research Partner: Hitgen
Description: DEL Library screen to find potential binding partner/therapeutic targets for PACS1 Syndrome.
Research commitment: $200,000
​
Institution: Northwestern University
Principal Investigator: Alicia D. Guemez-Gamboa, Ph.D.
Description: Uncover biomarkers of PACS1 Syndrome, results to be shared via an open-source data-sharing platform with PACS1 Foundation research partners.
Grant Amount: $25,000
​
Institution: The Broad Institute of MIT and Harvard
Research Partner: The Center for the Development of Therapeutics (CDoT), Joseph Growney, Ph.D., Director
Description: Cell-based screening study using patient fibroblasts.
Grant Amount: $15,000
​
2021
​
Institution: University of California
Principal Investigator: Yishi Jin, Ph.D.
Description: Continuation of the study of C. elegans model of PACS1 Syndrome to understand the genetics of the PACS1 Syndrome.
Grant Amount: $25,000
​
2020
​
Institution: Northwestern University
Principal Investigator: Alicia D. Guemez-Gamboa, Pd.D.
Description: Continuation of the study of neuronal models and human forebrain organoids of PACS1 Syndrome. Grant Amount: $65,000
​
Institution: University of California
Principal Investigator: Yishi Jin, Ph.D.
Description: Study of C. elegans model of PACS1 Syndrome to understand the genetics of the disease.
Grant Amount: $50,000
​
Institution: University of Pittsburgh
Principal Investigator: Gary Thomas, Ph.D.
Description: Mouse costs to build mouse models in PACS1 Syndrome.
Grant Amount: $30,705
​
Institution: University of Pittsburgh
Principal Investigator: Zachary Wills, Ph.D.
Description: Electrophysiological studies of mouse models of PACS1 Syndrome.
Grant Amount: $25,000
2019
Institution: University of Pittsburgh
Principal Investigator: Gary Thomas, Ph.D.
Description: Mouse costs to build mouse models of PACS1 Syndrome and equipment for a live-cell device to examine further cell biology of PACS1 Syndrome.
Grant Amount: $53,666
Institution: Northwestern University
Principal Investigator: Alicia D. Guemez-Gamboa, Pd.D.
Description: Study of neuronal models and human forebrain organoids of PACS1 Syndrome.
Grant Amount: $65,000
2018
Institution: University of Pittsburgh
Principal Investigator: Gary Thomas, Ph.D.
Description: Continuation of the study of cell biology of PACS1 Syndrome to uncover underlying disease mechanisms and provide new insights into fundamental disease biology and translational opportunities.
Grant Amount: $138,802
Institution: University of Pittsburgh
Principal Investigator: Angela Gronnenborn, Ph.D.
Description: Continuation of the study of structural biology of PACS1 Syndrome to provide new insights into fundamental disease biology and translational opportunities.
Grant Amount: $70,000
2017
Institution: University of Pittsburgh
Principal Investigator: Gary Thomas, Ph.D.
Description: Study of cell biology of PACS1 Syndrome to uncover underlying disease mechanisms and provide new insights into fundamental disease biology and translational opportunities.
Grant Amount: $107,539
Institution: University of Pittsburgh
Principal Investigator: Angela Gronnenborn, Ph.D.
Description: Study structural biology of PACS1 Syndrome to provide new insights into fundamental disease biology and translational opportunities.
Grant Amount: $40,000
Institution: Duke University Medical Center
Principal Investigator: Nicholas Katsanis, Ph.D.
Description: Zebrafish model to study PACS1 Syndrome.
Grant Amount: $64,590 ​​